Search results
The Zacks Analyst Blog Highlights Cigna Group, HCA Healthcare, Avantor and Tenet Healthcare
Zacks via Yahoo Finance· 4 days agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Reuters· 5 days agoCigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no...
CVS, Cigna's Evernorth lean into Humira biosimilars
Becker’s Hospital Review· 2 days agoAs some formularies begin to favor biosimilars, CVS Health and Cigna Group's Evernorth are veering further into the biosimilar business, The Wall Street Journal reported April ...
3 Dirt-Cheap Health Stocks to Buy on Weakness
InvestorPlace· 9 hours agoIndeed, swift policy shifts (lower Medicare rates), cybersecurity breaches and loftier medical costs will certainly cause quite a bit of industry-wide...
86% of expats report being stressed out, but study suggests they may also cope better with burnout
CNBC· 17 hours ago"The globally mobile – individuals living and working overseas – are an increasingly important...
Cigna Group [CI] Records 200-Day SMA of $307.61 – Knox Daily
Knox Daily· 5 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cigna Group shares valued at $11,084,357 were sold by Cordani David on ...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Reuters via Yahoo Finance· 5 days agoCigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no...
Cigna (CI) Stock Dips While Market Gains: Key Facts
Zacks via Yahoo Finance· 7 days agoIn the latest trading session, Cigna (CI) closed at $352.65, marking a -0.15% move from the previous day. The stock trailed the S&P 500, which registered...
Cigna (CI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks· 6 days agoFree Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in ...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy By Reuters
Investing.com· 5 days agoCigna said it will stock high- and low-concentration biosimilar versions of Humira from drugmakers...
